Rajiv Jalan

Rajiv Jalan

Rowland Hill Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 400 publications

Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].

Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].

Journal: Journal of hepatology

Published: July 25, 2026

Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis - Authors' reply.

Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis - Authors' reply.

Journal: The lancet. Gastroenterology & hepatology

Published: June 22, 2026

Reply to: "Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology".

Reply to: "Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology".

Journal: Journal of hepatology

Published: June 09, 2026

Reply to: "Not yet time to A-Tango in redefining acute-on-chronic liver failure".

Reply to: "Not yet time to A-Tango in redefining acute-on-chronic liver failure".

Journal: Journal of hepatology

Published: April 08, 2026

Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification.

Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification.

Journal: Journal of clinical and translational hepatology

Published: April 06, 2026

Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis.

Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis.

Journal: iMeta

Published: March 31, 2026

Refining ACLF diagnosis: Beyond the scorecard.

Refining ACLF diagnosis: Beyond the scorecard.

Journal: Journal of hepatology

Published: March 28, 2026

The role of ammonia in chronic liver disease.

The role of ammonia in chronic liver disease.

Journal: Hepatology communications

Published: March 27, 2026

The illusion of harmonisation in ACLF.

The illusion of harmonisation in ACLF.

Journal: Journal of hepatology

Published: March 22, 2026

Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship.

Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship.

Journal: The lancet. Gastroenterology & hepatology

Published: February 11, 2026

Editorial: Dysfunctional Neutrophils in Cirrhosis With Acute Decompensation-Why It Matters. Authors' Reply.

Editorial: Dysfunctional Neutrophils in Cirrhosis With Acute Decompensation-Why It Matters. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 17, 2025

A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.

A randomized, open-label, Phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis.

Journal: Hepatology (Baltimore, Md.)

Published: December 04, 2025

Showing 1-12 of 400

Last Updated: 09/26/2026